Bank of New York Mellon’s Clearside Biomedical CLSD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | – | Sell |
-29,519
| Closed | -$34.5K | – | 4180 |
|
2023
Q4 | $34.5K | Hold |
29,519
| – | – | ﹤0.01% | 4183 |
|
2023
Q3 | $25.7K | Hold |
29,519
| – | – | ﹤0.01% | 4218 |
|
2023
Q2 | $33.1K | Hold |
29,519
| – | – | ﹤0.01% | 4222 |
|
2023
Q1 | $30.7K | Hold |
29,519
| – | – | ﹤0.01% | 4257 |
|
2022
Q4 | $33.1K | Hold |
29,519
| – | – | ﹤0.01% | 4290 |
|
2022
Q3 | $33K | Hold |
29,519
| – | – | ﹤0.01% | 4381 |
|
2022
Q2 | $43K | Sell |
29,519
-1,276
| -4% | -$1.86K | ﹤0.01% | 4376 |
|
2022
Q1 | $71K | Hold |
30,795
| – | – | ﹤0.01% | 4470 |
|
2021
Q4 | $85K | Hold |
30,795
| – | – | ﹤0.01% | 4423 |
|
2021
Q3 | $185K | Buy |
30,795
+11,692
| +61% | +$70.2K | ﹤0.01% | 4229 |
|
2021
Q2 | $93K | Hold |
19,103
| – | – | ﹤0.01% | 4223 |
|
2021
Q1 | $47K | Sell |
19,103
-1,906
| -9% | -$4.69K | ﹤0.01% | 4267 |
|
2020
Q4 | $58K | Hold |
21,009
| – | – | ﹤0.01% | 4136 |
|
2020
Q3 | $32K | Hold |
21,009
| – | – | ﹤0.01% | 4062 |
|
2020
Q2 | $39K | Hold |
21,009
| – | – | ﹤0.01% | 4006 |
|
2020
Q1 | $36K | Hold |
21,009
| – | – | ﹤0.01% | 4003 |
|
2019
Q4 | $61K | Hold |
21,009
| – | – | ﹤0.01% | 4080 |
|
2019
Q3 | $13K | Sell |
21,009
-27,234
| -56% | -$16.9K | ﹤0.01% | 4193 |
|
2019
Q2 | $47K | Sell |
48,243
-62,057
| -56% | -$60.5K | ﹤0.01% | 4117 |
|
2019
Q1 | $152K | Sell |
110,300
-1,670
| -1% | -$2.3K | ﹤0.01% | 3928 |
|
2018
Q4 | $120K | Buy |
111,970
+27,652
| +33% | +$29.6K | ﹤0.01% | 3930 |
|
2018
Q3 | $519K | Buy |
84,318
+3,798
| +5% | +$23.4K | ﹤0.01% | 3629 |
|
2018
Q2 | $861K | Sell |
80,520
-68,276
| -46% | -$730K | ﹤0.01% | 3328 |
|
2018
Q1 | $1.6M | Buy |
148,796
+58,075
| +64% | +$623K | ﹤0.01% | 2935 |
|
2017
Q4 | $636K | Sell |
90,721
-286
| -0.3% | -$2.01K | ﹤0.01% | 3490 |
|
2017
Q3 | $795K | Sell |
91,007
-2,493
| -3% | -$21.8K | ﹤0.01% | 3351 |
|
2017
Q2 | $852K | Buy |
93,500
+58,677
| +169% | +$535K | ﹤0.01% | 3341 |
|
2017
Q1 | $277K | Buy |
34,823
+3,404
| +11% | +$27.1K | ﹤0.01% | 3770 |
|
2016
Q4 | $281K | Buy |
31,419
+14,721
| +88% | +$132K | ﹤0.01% | 3800 |
|
2016
Q3 | $289K | Buy |
+16,698
| New | +$289K | ﹤0.01% | 3770 |
|